TY  - GEN
AU  - Patel,Hetal
AU  - Periyasamy,Manikandan
AU  - Sava,Georgina P
AU  - Bondke,Alexander
AU  - Slafer,Brian W
AU  - Kroll,Sebastian H B
AU  - Barbazanges,Marion
AU  - Starkey,Richard
AU  - Ottaviani,Silvia
AU  - Harrod,Alison
AU  - Aboagye,Eric O
AU  - Buluwela,Laki
AU  - Fuchter,Matthew J
AU  - Barrett,Anthony G M
AU  - Coombes,R Charles
AU  - Ali,Simak
TI  - ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
SN  - 1538-8514
PY  - 2019///0625
KW  - Administration, Oral
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Biological Availability
KW  - Caspases
KW  - metabolism
KW  - Cell Cycle
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cyclin-Dependent Kinases
KW  - antagonists & inhibitors
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Humans
KW  - Mice
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - Xenograft Model Antitumor Assays
KW  - Cyclin-Dependent Kinase-Activating Kinase
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1535-7163.MCT-16-0847
ER  -